Form 4 Tracker
Sarah Gheuens

Chief Medical Officer; Director · 6 filings · Latest: Aug 4, 2026

AGIOS PHARMACEUTICALS, INC.
Viridian Therapeutics, Inc.\DE
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
AGIO
Sarah GheuensChief Medical OfficerAug 4, 2026
Sale
$30.4830,000$914.4K54,645
AGIO
SARAH GHEUENS—Aug 4, 2026
Proposed Sale
$30.4830,000$914.3K—
AGIO
Sarah GheuensChief Medical OfficerJul 1, 2026
Sale
$37.564,007$150.5K84,645
AGIO
Sarah GheuensChief Medical OfficerJul 1, 2026
Option Exercise
$0.008,375—88,652
AGIO
Gheuens Sarah—Jul 1, 2026
Proposed Sale
$37.564,007$150.5K—
AGIO
Sarah GheuensChief Medical OfficerApr 2, 2026
Sale
$34.712,940$102.0K80,277
AGIO
Sarah GheuensChief Medical OfficerApr 2, 2026
Option Exercise
$0.008,500—83,217
AGIO
Gheuens Sarah—Apr 2, 2026
Proposed Sale
$34.192,940$100.5K—
AGIO
Sarah GheuensChief Medical OfficerMar 2, 2026
Sale
$28.964,055$117.4K74,406
AGIO
Sarah GheuensChief Medical OfficerMar 2, 2026
Option Exercise
$0.0013,666—75,593
AGIO
Gheuens Sarah—Mar 2, 2026
Proposed Sale
$30.234,055$122.6K—
AGIO
Gheuens Sarah—Dec 30, 2025
Proposed Sale
$27.162,932$79.6K—
AGIO
SARAH GHEUENS—Nov 11, 2025
Proposed Sale
$43.782,454$107.4K—
AGIO
SARAH GHEUENS—Oct 30, 2025
Proposed Sale
$43.81200$8.8K—
AGIO
SARAH GHEUENS—Oct 27, 2025
Proposed Sale
$43.923,302$145.0K—
AGIO
SARAH GHEUENS—Jul 9, 2025
Proposed Sale
$37.9911,914$452.6K—
AGIO
Gheuens Sarah—Jul 1, 2025
Proposed Sale
$34.374,091$140.6K—
AGIO
Gheuens Sarah—Jun 24, 2025
Proposed Sale
$34.411,761$60.6K—
AGIO
Gheuens Sarah—Mar 3, 2025
Proposed Sale
$35.544,005$142.3K—